HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2 + Tumors

Cancer Research - United States
doi 10.1158/0008-5472.can-16-2247
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Salmonella Exploits NLRP12-dependent Innate Immune Signaling to Suppress Host Defenses During Infection

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2013English

The HDAC Inhibitor LBH589 (Panobinostat) Is an Inhibitory Modulator of Aromatase Gene Expression

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2010English

Host Histone Acetylation Unlocks HDAC Inhibitor Potential

Oncotarget
Oncology
2017English

Human Cytomegalovirus Glycoprotein UL141 Targets the TRAIL Death Receptors to Thwart Host Innate Antiviral Defenses

Cell Host and Microbe
ImmunologyMolecular BiologyCancer ResearchVirologyMicrobiologyMicrobiology Parasitology
2013English

Dengue Virus and the Host Innate Immune Response

Emerging Microbes and Infections
ImmunologyVirologyMicrobiologyEpidemiologyParasitologyMedicineDrug DiscoveryInfectious Diseases
2018English

The HDAC Inhibitor LBH589 Enhances the Antimyeloma Effects of the IGF-1RTK Inhibitor Picropodophyllin

Clinical Cancer Research
Cancer ResearchOncology
2012English

Inhibitors of HSP90 Block P95-Her2 Signaling in Trastuzumab-Resistant Tumors and Suppress Their Growth

Oncogene
Cancer ResearchGeneticsMolecular Biology
2009English

HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-Pd-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment

Journal of Cancer
Oncology
2020English

Cytokeratin 5/6 Fingerprinting in HER2-positive Tumors Identifies a Poor Prognosis and Trastuzumab-Resistant Basal-Her2 Subtype of Breast Cancer

Oncotarget
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy